Related references
Note: Only part of the references are listed.Experimental Evaluation of Anticancer Efficiency and Acute Toxicity of Anthrafuran for Oral Administration
Andrey E. Shchekotikhin et al.
PHARMACEUTICALS (2020)
New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties
Yulia L. Volodina et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma
Zhenjiang Zhao et al.
MOLECULAR CARCINOGENESIS (2019)
Intrinsic tryptophan fluorescence spectroscopy reliably determines galectin-ligand interactions
Paulina Sindrewicz et al.
SCIENTIFIC REPORTS (2019)
Liposomal Annamycin - A New Generation Anthracycline That Overcomes MDR and Has No Cardiac Toxicity for the Second Line Treatment of R/R AML
Robert Shepard
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)
The functional diversity of Aurora kinases: a comprehensive review
Estelle Willems et al.
CELL DIVISION (2018)
Aurora B: A new promising therapeutic target in cancer
Paolo Chieffi
INTRACTABLE & RARE DISEASES RESEARCH (2018)
Recent Advances in Scaffold Hopping
Ye Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Heterocyclic Analogs of 5,12-Naphthacenequinone 14*. Synthesis of naphtho[2,3-f]indole-3-carboxylic Acid Derivatives
Alexander S. Tikhomirov et al.
CHEMISTRY OF HETEROCYCLIC COMPOUNDS (2017)
Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties
Andrey E. Shchekotikhin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structural Biology Insight for the Design of Sub-type Selective Aurora Kinase Inhibitors
Sailu Sarvagalla et al.
CURRENT CANCER DRUG TARGETS (2015)
Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells
Susanna Cogoi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells
Gustav Holmgren et al.
TOXICOLOGY (2015)
Knockdown of Aurora-B inhibits the growth of non-small cell lung cancer A549 cells
Jing Jing Yu et al.
ONCOLOGY LETTERS (2015)
A Cell Biologist's Field Guide to Aurora Kinase Inhibitors
Christian O. de Groot et al.
FRONTIERS IN ONCOLOGY (2015)
Aurora Kinase inhibitors: Current Status and Outlook
Vassilios Bavetsias et al.
FRONTIERS IN ONCOLOGY (2015)
Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones
Andrey E. Shchekotikhin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Classification of scaffold-hopping approaches
Hongmao Sun et al.
DRUG DISCOVERY TODAY (2012)
Crystal Structure of Human Aurora B in Complex with INCENP and VX-680
Jonathan M. Elkins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Evidence that Aurora B is implicated in spindle checkpoint signalling independently of error correction
Stefano Santaguida et al.
EMBO JOURNAL (2011)
A Novel Mode of Protein Kinase Inhibition Exploiting Hydrophobic Motifs of Autoinhibited Kinases DISCOVERY OF ATP-INDEPENDENT INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR
Sudharshan Eathiraj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer
Zhannat Nurgalieva et al.
MEDICAL ONCOLOGY (2011)
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
Zhong-Zhe Lin et al.
BMC CANCER (2010)
Expression profiling identifies epoxy anthraquinone derivative as a DNA topoisomerase inhibitor
Jinesh Gheeya et al.
CANCER LETTERS (2010)
Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization
Joy Concepcion et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2009)
Heterocyclic analogs of 5,12-naphthacenequinone 7. Synthesis of naphtho-[2,3-f]isatin-5,10-dione derivatives
A. E. Shchekotikhin et al.
CHEMISTRY OF HETEROCYCLIC COMPOUNDS (2008)
An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins
Vassilios Myrianthopoulos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Aurora kinase targeted therapeutics in oncology: past, present and future
Daruka Mahadevan et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis
Robert W. Wilkinson et al.
CLINICAL CANCER RESEARCH (2007)
9-nitroanthracene derivative as a precursor of anthraquinone for photodynamic therapy
Kiyoshi Fukuhara et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Anthracyclines as effective anticancer drugs
Janos Nadas et al.
EXPERT OPINION ON DRUG DISCOVERY (2006)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Validating Aurora B as an anti-cancer drug target
Fiona Girdler et al.
JOURNAL OF CELL SCIENCE (2006)
Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase
H Yang et al.
FEBS LETTERS (2005)
Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation
R Sorrentino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Progress in the development of selective inhibitors of aurora kinases (vol 5, pg 199, 2005)
A Mortlock et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Inhibitors of Aurora kinases for the treatment of cancer
D Fancelli et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
Aurora-kinase inhibitors as anticancer agents
N Keen et al.
NATURE REVIEWS CANCER (2004)
Mitotic mechanics: the auroras come into view
PD Andrews et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
The cellular geography of aurora kinases
M Carmena et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores
C Ditchfield et al.
JOURNAL OF CELL BIOLOGY (2003)
The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint
S Hauf et al.
JOURNAL OF CELL BIOLOGY (2003)
Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis
MJ Kallio et al.
CURRENT BIOLOGY (2002)
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation
C Sakakura et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
